Lv21
108 积分 2022-06-27 加入
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study
44分钟前
已完结
USP14-IMP2-CXCL2 axis in tumor-associated macrophages facilitates resistance to anti-PD-1 therapy in gastric cancer by recruiting myeloid-derived suppressor cells
12天前
已完结
Distinct Inflammatory Cytotoxic T Lymphocyte Populations Mediate PD-1 Blockade–Induced Immune-Related Adverse Events in Multiple Organs
14天前
已完结
CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-off
15天前
已完结
The association between tumor burden and severe immune-related adverse events in non-small cell lung cancer patients responding to immune-checkpoint inhibitor treatment
25天前
已完结
Relation of overall tumor burden with severe immune-related adverse events in nivolumab plus ipilimumab treatment for lung cancer
25天前
已完结
Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting
29天前
已完结
An analysis of single-cell data reveals therapeutic effects of AMG487 in experimental autoimmune uveitis
1个月前
已完结
Effect of steroid therapy on survival in patients with metastatic solid tumors experiencing immune-related adverse events
1个月前
已完结
Interleukin-6 blockade for prophylaxis and management of immune-related adverse events in cancer immunotherapy
1个月前
已完结
皖公网安备34019202002308
